These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19638691)

  • 1. [Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker].
    Okuno S; Inaba M
    Clin Calcium; 2009 Aug; 19(8):1084-91. PubMed ID: 19638691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological analysis of bone dynamics and metabolic bone disease. Renal Osteodystrophy and New KDIGO CKD-MBD classification].
    Tsukamoto Y
    Clin Calcium; 2011 Apr; 21(4):593-7. PubMed ID: 21447928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone metabolism in CKD-MBD].
    Kazama JJ
    Clin Calcium; 2010 Jul; 20(7):1038-44. PubMed ID: 20585182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2009 Aug; 19(8):1075-82. PubMed ID: 19638690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary osteoporosis UPDATE. Therapy for bone-mineral disease in CKD-5D patients].
    Orita H; Yoshimoto W; Tanaka Y; Yamanaka S; Shigematsu T
    Clin Calcium; 2010 May; 20(5):752-7. PubMed ID: 20445287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic kidney disease (CKD) and bone. From renal osteodystrophy to CKD-MBD: new disease entity].
    Tsukamoto Y
    Clin Calcium; 2009 Apr; 19(4):479-84. PubMed ID: 19329825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidney and bone update : the 5-year history and future of CKD-MBD. Mineral and bone disorder in kidney transplant recipients].
    Fujii N; Okuno A; Yonemoto S; Nishimura K; Kishikawa H; Ichikawa Y
    Clin Calcium; 2012 Jul; 22(7):1050-8. PubMed ID: 22750938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. News on biomarkers in CKD-MBD.
    Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
    Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline].
    Yokoyama K
    Clin Calcium; 2010 Jul; 20(7):1012-20. PubMed ID: 20585179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving global outcomes in mineral and bone disorders.
    Moe SM; Drüeke T
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S127-30. PubMed ID: 18988697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic markers of bone and clinical use].
    Miki T; Naka H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():221-6. PubMed ID: 18161110
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone markers predict cardiovascular events in chronic kidney disease.
    Fahrleitner-Pammer A; Herberth J; Browning SR; Obermayer-Pietsch B; Wirnsberger G; Holzer H; Dobnig H; Malluche HH
    J Bone Miner Res; 2008 Nov; 23(11):1850-8. PubMed ID: 18597636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
    Haarhaus M; Fernström A; Magnusson M; Magnusson P
    Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
    Yokoyama K
    Clin Calcium; 2012 Jul; 22(7):979-86. PubMed ID: 22750929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal osteodystrophy and vitamin K. Vitamin K and dialysis].
    Okuno S; Ishimura E
    Clin Calcium; 2007 Nov; 17(11):1745-50. PubMed ID: 17982196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological analysis of bone dynamics and metabolic bone disease. Bone Histomorphometry in CKD-MBD (chronic kidney disease mineral bone disorder)].
    Yamamoto N
    Clin Calcium; 2011 Apr; 21(4):589-92. PubMed ID: 21447927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.